Working with patient organisations

At present the number of European patients able to access medicinal cannabis is estimated to be over 100,000* . However, as EU governments review and revise their guidelines, over 25 million patients may be able to access medicinal cannabis over the next 10 years in Europe**. This represents a massive unmet need for medicinal cannabis treatments, across a broad range of medical conditions, especially in the area of Pain Management.

*German Cannabis Report October 2018
**EU Cannabis Report January 2019

 

Key Priorities

Removing the regulatory and prescribing hurdles of pharmaceutical-grade medicinal cannabis in the EU and member states will enable innovative products to reach patients in a timely manner.

This requires co-operation and cross-working between the EUMCA and the wider industry stakeholders, including: 

  • Working with governments and healthcare professionals to assist and aid in their understanding of the benefits of cannabis for medicinal purposes
  • Working with patient organisations to reduce inequalities for patients accessing medicinal cannabis-based medicines throughout the EU
  • Working and collaborating with medical research charities and patient organisations to widen our scientific understanding on the benefits of medicinal cannabis and develop ethical, comprehensive educational materials which provide balanced, scientific information on its benefits
  • Creating a transparent, credible and evidence-based knowledge exchange between medicinal cannabis stakeholders and patient organisations
  • Ensuring that all key marketing communications are presented to patients in a standardised and ethical manner

Key Priorities

Removing the regulatory and prescribing hurdles of pharmaceutical-grade medicinal cannabis in the EU and member states will enable innovative products to reach patients in a timely manner.

This requires co-operation and cross-working between the EUMCA and the wider industry stakeholders, including: 

  • Working with governments and healthcare professionals to assist and aid in their understanding of the benefits of cannabis for medicinal purposes 
  • Working with patient organisations to reduce inequalities for patients accessing medicinal cannabis-based medicines throughout the EU 
  • Working and collaborating with medical research charities and patient organisations to widen our scientific understanding on the benefits of medicinal cannabis and develop ethical, comprehensive educational materials which provide balanced, scientific information on its benefits 
  • Creating a transparent, credible and evidence-based knowledge exchange between medicinal cannabis stakeholders and patient organisations 
  • Ensuring that all key marketing communications are presented to patients in a standardised and ethical manner

Our Vision

To advance patient access to medicinal cannabis treatments, and improve the health outcomes of patients across Europe

Our Mission

In order to improve the life and health outcomes of patients across Europe, the EUMCA facilitates the development of national government healthcare policies that advocates for the ethical prescription of pharmaceutical-grade medicinal cannabis, and advance patient access to treatments

If you are a Patient Association or Patient Advocacy Group interested in joining the EUMCA, please contact us on info@eumca.org or call +32 233 90 281

Our Vision

To advance patient access to medicinal cannabis treatments, and improve the health outcomes of patients across Europe

Our Mission

In order to improve the life and health outcomes of patients across Europe, the EUMCA facilitates the development of national government healthcare policies that advocate the ethical prescription of pharmaceutical-grade medicinal cannabis, and advance patient access to treatments

 

If you are a Patient Association or Patient Advocacy Group interested in joining the EUMCA, please contact us on info@eumca.org or call +32 233 90 281 

Get in touch

Please submit your membership enquiry and our team will be in touch to discuss

Or call +32 233 90 281

+32 233 90 281

info@eumca.org

EUMCA, Brussels, Belgium

Copyright ©2019 EUROPEAN MEDICINAL CANNABIS ASSOCIATION

Address: EUMCA, Immobilière du Noyer S.A.
Avenue Adolphe Lacomblé 69-71
B-1030 Bruxelles

Phone: +32 233 90 281

Linkedin: EUMCA

Twitter: @EUMCAOrg

Privacy policy: View here

Website by
Copyright ©2019 EUROPEAN MEDICINAL CANNABIS ASSOCIATION

Address: EUMCA, Immobilière du Noyer S.A.
Avenue Adolphe Lacomblé 69-71
B-1030 Bruxelles

Phone: +32 233 90 281

Linkedin: EUMCA

Twitter: @EUMCAOrg

Privacy policy: View here

Website by

WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly